Study to Evaluate Long Term Immunogenicity up to 10 Years After the First Booster Immunization With Tick Borne Encephalitis Vaccine in Adults Who Received 1 of 3 Different Primary Vaccination Schedules

Condition:   Tick Borne EncephalitisIntervention:   Other: Blood SamplingSponsors:   Novartis;   Novartis VaccinesActive, not recruiting - verified November 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials